| April Michelle Patellis, CRNP | |
|
382 Slaughter Rd, Madison, AL 35758-2008 | |
| (257) 428-1096 | |
| (256) 428-1098 |
| Full Name | April Michelle Patellis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 382 Slaughter Rd, Madison, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376599035 | NPI | - | NPPES |
| 51526779 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0816-2048C (Alabama) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 1-180183 (Alabama) | Primary |
| Entity Name | Tennessee Valley Internal Medicine, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174892780 PECOS PAC ID: 1759548092 Enrollment ID: O20120130000187 |
News Archive
An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
The event began with talk of knocked-out teeth and ended with a feel-good huddle. Michael Wright, DDS '99, MS, and three professional athletes visited the Dr. Samuel D. Harris National Museum of Dentistry and the University of Maryland School of Dentistry to help spread awareness about avoiding injuries to the mouth and face.
The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
› Verified 5 days ago
| Entity Name | Mid-south Home Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922535400 PECOS PAC ID: 4385961093 Enrollment ID: O20171031002020 |
News Archive
An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
The event began with talk of knocked-out teeth and ended with a feel-good huddle. Michael Wright, DDS '99, MS, and three professional athletes visited the Dr. Samuel D. Harris National Museum of Dentistry and the University of Maryland School of Dentistry to help spread awareness about avoiding injuries to the mouth and face.
The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April Michelle Patellis, CRNP 382 Slaughter Rd, Madison, AL 35758-2008 Ph: (257) 428-1096 | April Michelle Patellis, CRNP 382 Slaughter Rd, Madison, AL 35758-2008 Ph: (257) 428-1096 |
News Archive
An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
The event began with talk of knocked-out teeth and ended with a feel-good huddle. Michael Wright, DDS '99, MS, and three professional athletes visited the Dr. Samuel D. Harris National Museum of Dentistry and the University of Maryland School of Dentistry to help spread awareness about avoiding injuries to the mouth and face.
The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
› Verified 5 days ago